Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla
Cipla
BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
399.65
2.3 (0.58%)
VOLUME 58,655
LIVE
NSE
Apr 23, 17:00
399.05
2.55 (0.64%)
VOLUME 748,544
News on Cipla
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dipan Mehta positive on pharma sector 

2.04 pm | 22 Apr 2014 |  Source: CNBC-TV18

Dipan Mehta, member at BSE & NSE is positive on pharma sector....

Buy Cipla on correction: Phani Sekhar 

3.19 pm | 07 Apr 2014 |  Source: CNBC-TV18

Phani Sekhar of Angel Broking advises buying Cipla on dips. ...

Top 10 stocks: Keey an eye on Sun,Ranbaxy,Cipla,HDIL 

10.23 am | 07 Apr 2014 |  Source: CNBC-TV18

Here are the top 10 stocks picked by CNBC-TV18’s research team to keep a watch on - Sun Pharma, Ranbaxy, Cipla, Reliance Infra, India VIX Futures, G...

Buy Cipla 400 Call, says VK Sharma 

11.00 am | 04 Apr 2014 |  Source: CNBC-TV18

VK Sharma of HDFC Securities is of the view that one may buy Cipla 400 Call at Rs 10....

Keep Cipla in portfolio, avoid Wockhardt: Gopi Suvanam 

5.10 pm | 03 Apr 2014 |  Source: CNBC-TV18

Gopi Suvanam, founder at InvestWorks prefers Ranbaxy Laboratories, Sun Pharmaceutical Industries, Lupin and Cipla. He feels that one should avoid Wock...

Cipla appoints Rajesh Garg as wholetime director

12.12 pm | 01 Apr 2014 |  Source: Moneycontrol.com

Cipla has submitted a copy of abstract under section 302 of the Companies Act, 1956 relating to the appointment of Mr. Rajesh Garg as Wholetime Direct...

Cipla shifts its registered office

9.00 am | 01 Apr 2014 |  Source: Moneycontrol.com

Cipla has informed that with effect from April 01, 2014 the Registered Office of the Company will be shifted from Mumbai Central, Mumbai - 400 008 to ...

Buy Cipla: Sudarshan Sukhani 

10.14 am | 24 Mar 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Cipla....

Expect lower levels in Cipla, says Sudarshan Sukhani 

10.35 am | 20 Mar 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may see lower levels in Cipla....

Cipla may move to Rs 402: SP Tulsian 

10.18 am | 18 Mar 2014 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com feels that Cipla may move to Rs 402....

Religare downgrades Cipla on cost overruns 

5.54 pm | 13 Feb 2014 |  Source: CNBC-TV18

Arvind Bothra of Religare Capital Markets expects Cipla's full margins to be 20-21 percent. But adds if scale up in R&D continues at this pace and app...

FY15 capex Rs 400 cr, aiming for 20% EBITDA growth: Cipla 

10.18 am | 13 Feb 2014 |  Source: CNBC-TV18

Rajesh Garg, global chief financial officer, Cipla, told CNBC-TV18 that operating profits were impacted in the absence of anti-depressant Escitalopram...

Cipla Q3 net falls 23% on weak operational performance

6.35 pm | 12 Feb 2014 |  Source: Moneycontrol.com

Net sales grew 10 percent to Rs 2,281 crore from Rs 2,079 crore during the same period while total expenses jumped 18 percent to Rs 1,961 crore compar...

Cipla Q3 PAT may rise 6.1% to Rs 360 cr: CNBC-TV18 poll 

10.26 am | 12 Feb 2014 |  Source: CNBC-TV18

Analysts feel profit after tax of Cipla may come in as low as Rs 300 crore during the quarter due to margin pressure....

Pharma companies revenues to rise 12% in Q3: Anand Rathi

5.34 pm | 03 Jan 2014 |  Source: Moneycontrol.com

Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), re...

Hold Cipla; target Rs 442: Firstcall Research

1.44 pm | 25 Nov 2013 |  Source: Moneycontrol.com

Brokerage house Firstcall Research has recommended a hold rating on Cipla with a target price of Rs 442, in its November 19, 2013 research report....

H1 inline; Cipla Medpro fully integrated: Cipla MD 

7.41 pm | 13 Nov 2013 |  Source: CNBC-TV18

Cipla MD & Global CEO Subhanu Saxena says he had signaled that the first 12-18 months in its roadmap was investing in the business for the future - pa...

Cipla Q2 net falls 28.4% to Rs 358 cr, margin slips 850 bps

6.08 pm | 13 Nov 2013 |  Source: Moneycontrol.com

Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) fell 16.7 percent Y-o-Y to Rs 564 crore and operating profit margin...

Cipla Q2 PAT may dip 27.3% at Rs 363.3 cr: ICICIdirect

11.04 am | 13 Nov 2013 |  Source: Moneycontrol.com

Revenues of Cipla are expected to decrease by 0.6 percent Q-o-Q (up 11.7 percent Y-o-Y) to Rs 2448.9 crore....

1 2 3 4
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.